Worldwide Insights Into the Patient Recruitment & Retention Services Market, 2019-2030 - Growing Demand for Orphan Drugs and Personalized Medicine
DUBLIN, May 7, 2019 /PRNewswire/ -- The "Patient Recruitment and Retention Services Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.
Patient Recruitment and Retention Services, 2019-2030
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain.
One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030.
In addition, we have segmented the future opportunity across:
-- [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others) -- [B] steps in patient recruitment process (pre-screening and screening) -- [C] phases of development (phase I, phase II, phase III and phase IV) -- [D] different global regions (North America, Europe, Asia-Pacific and rest of the world)
In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.
Market Insights
Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose immense financial pressure on sponsors.
Amongst several known challenges, patient recruitment is considered to be one of the rate-limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don't even enroll a single patient.
In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit/retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.
The above-mentioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research.
Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs / personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future.
In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.
Key Topics Covered
1. Preface
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. Executive Summary
3. Patient Recruitment And Retention In Clinical Trials
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services
4. Patient Outreach Methods
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach
5. Competitive Market Landscape Of Patient Recruitment And Retention Service Providers
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
6. Company Competitiveness Analysis
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies
7. Company Profiles
7.1. Chapter Overview
7.2. Patient Recruitment Service Providers in North America
7.2.1. Acurian
7.2.2. BBK Worldwide
7.2.3. Bright Pharmaceuticals Services
7.2.4. ClinEdge
7.2.5. CSSi
7.2.6. CTM
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.8. MMG
7.2.9. Topstone Research
7.2.10. WCCT Global
7.3. Patient Recruitment Service Providers in Europe
7.3.1. Antidote
7.3.2. Fidelis Research
7.3.3. Ignite Data
7.3.4. Polaris BioPharma Consulting
7.3.5. Tudor Reilly Health
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROe
7.4.2. Jsure Healthmedia
7.4.3. TrialWire
7.4.4. Pacific Groove
8. Partnerships And Collaborations
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis
9. Recent Trends In Patient Recruitment And Retention
9.1. Chapter Overview
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets
10. Future Growth Opportunities
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing
11. Market Sizing And Opportunity Analysis
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
12. Conclusion
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade
13. Interview Transcripts
13.1. Chapter Overview
13.2. Link2Trials
13.3. nRollmed
13.4. Seeker Health
Companies Mentioned
1. Abnex 2. Access Clinical Research 3. Accurate Clinical Research 4. Acurian 5. AD VERBUM 6. Advanced Clinical 7. Affordable Clinical Trials Outsourcing 8. Akcelis 9. Alleco Trials 10. Alliance for Clinical Research Excellence and Safety 11. Allscripts 12. American Liver Foundation 13. American Society of Clinical Oncology 14. Amgen 15. Antidote 16. ApotheCom 17. Apparelyzed 18. Apptomics 19. AQLANE Medical 20. Arden and Schmidt 21. AstraZeneca 22. ATLAS Medical Services 23. AutoCruitment 24. AXELLE Group 25. Axiom Marketing 26. BBK Worldwide 27. BDD 28. BIAPharm 29. Bio-Optronics 30. Bioclinica 31. BioScript 32. Bladder & Bowel Community 33. Blueprint Clinical 34. BlueTheory Clinical Trials 35. BMC Group 36. Box 37. Bridge Clinical Research 38. Bright Pharmaceutical Services 39. Buzzreach 40. C&C Clinical Laboratory Consulting 41. Canadian Institute for Medical Advancement 42. Capsule Communications 43. CaringKind 44. CarthagoPharma 45. Center Point Clinical Services 46. Centricity Health 47. Chandler Chicco Agency 48. Chase Medical Research 49. Cinven 50. Circuit Clinical 51. Clariness 52. Clear Clinica 53. Clinart MENA 54. ClinEdge 55. Clinerion 56. Clinical Ambassador 57. Clinical List America 58. Clinical Trial 59. Clinical Trial Connect 60. Clinical Trial Marketing Communications 61. Clinical Trial Networking 62. Clinical Trials Center 63. Clinical Trials Group 64. ClinicalConnection 65. Clinically Media 66. ClinIntel 67. CliniSpan Health 68. Clinspire Research 69. Clintec 70. Clintract 71. Clinverse 72. CMX Research 73. Compass Research 74. Continuum Clinical 75. CPS Research 76. CROee 77. CSSi 78. CTM 79. Cyclone 80. Cytespace 81. DAC Patient Recruitment Services 82. DAVA Oncology 83. DrFirst 84. Eastern Medical 85. Effectus CTR 86. EGeen 87. Elligo Health Research 88. EmergingMed 89. eNre 90. ePatientFinder 91. eStudySite 92. Euclid SR Partners 93. European Organization for Research and Treatment of Cancer 94. EVERSANA 95. FDAMap 96. Fidelis Research 97. Flatiron Health 98. Foundation for the National Institutes of Health 99. Foundation Medicine 100. Friends of Cancer Research 101. Gaea Clinical 102. Galen Patient Recruitment 103. GCP Clinical Studies 104. Genentech 105. Gitzo Pharmaceuticals 106. Global Clinical Trials 107. Global Perspectives 108. GuideStar Research 109. Heron Therapeutics 110. Ignite Data 111. IMS Health 112. Incontinence UK 113. Innovative Trials 114. INSPIRE 115. Institute of Clinical Research India 116. Integrated Clinical Trial Services 117. IQVIA 118. IRM 119. J Trotter Research & Consulting 120. JLL Partners 121. JP Morgan Partners 122. KCR 123. Klick Health 124. Langland 125. LeadSlinger 126. Linical Accelovance 127. Link2Trials 128. Live Doctors 129. LongTaal 130. Lyft 131. Lymphoma Action 132. Medical Research South 133. MediciGroup 134. Melanoma Research Alliance 135. Merck Capital Ventures 136. Miami Research Associates 137. MMG 138. Mondosano 139. Mundipharma Research 140. National Cancer Institute 141. Northumbria Healthcare NHS Foundation Trust 142. nRollmed 143. O4 Research 144. One Research 145. orphan reach 146. Orphanos 147. Osaka International Cancer Institute 148. Pacific Grove 149. Parallel 6 150. PAREXEL 151. Patient Enrollment Advisors 152. Patient RM 153. PatientEvolution 154. Patients Direct 155. PatientWise 156. Patiro 157. Pepgra 158. Pfizer 159. Pharm-Olam 160. PharmaCentra 161. Pharmaceutical Product Development 162. phaware global association 163. Physicians Plasma Alliance 164. Polaris Biopharma Consulting 165. PPH plus 166. Practice Fusion 167. Praxis Communications 168. PRC Clinical 169. Profil 170. ProQuest Investments 171. Publicis Healthcare Communications Group 172. PWNHealth 173. QPS 174. Radiant Research 175. RealTime Software Solutions 176. RemediumOne 177. Remedy Health Media 178. Rep Network 179. RESolutions 180. Roche 181. S4 Research 182. Seeker Health 183. Sinque Labs 184. SitePartner 185. SMO Clinical Research 186. SMO ClinPlus 187. Society for Clinical Research Sites 188. Spectrum Clinical Research 189. Spinal Cord Injury Network 190. Splash Clinical 191. SubjectWell 192. SWOG Cancer Research 193. Syneos Health 194. Synexus 195. TFS 196. The Academic Network 197. The Patient Experience Project 198. The Patient Recruiting Agency 199. The Patient Recruitment Consultancy 200. ThreeWire 201. Topstone Research 202. Total Clinical Trial Management 203. Trial Connections 204. Trialfacts 205. TrialJoin 206. TrialSpark 207. TrialWire 208. Tudor Reilly Health 209. United BioSource 210. University of Exeter 211. University of Glasgow 212. University of Strathclyde 213. Veristat 214. Viomedo 215. VisibilityRx 216. Vizae Clinical Trial Management 217. WCCT Global 218. WIRB-Copernicus Group 219. Worldwide Clinical Trials 220. X Factor Advertising
For more information about this report visit https://www.researchandmarkets.com/r/aj67yw
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets